Why Acutus Medical Shares Are Rallying Today?

• Acutus Medical Inc (NASDAQ: AFIB) has launched an expanded suite of left-heart access products, including the AcQCross Qx system for use with the TruSeal and FXD delivery system for the Watchman LAAC Device.

• AcQCross is a transseptal system engineered with an integrated needle and dilator to reduce the multiple exchanges of wires and needles while trying to achieve the proper angle and location on the septum.

• Related: Acutus Medical Stock Soars On Debt Refinancing, Divestiture Of Left-Heart Access Portfolio.

• With this clearance, Acutus now offers sheath-compatible transseptal access devices covering 409,000 electrophysiology and structural heart procedures in the U.S.

• Acutus Medical is an arrhythmia management company focused on improving how cardiac arrhythmias are diagnosed and treated.

• Price Action: AFIB shares are up 104.31% at $1.10 during the premarket session on the last check Monday.

See more from Benzinga

• Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why

• EMA's Advisory Committee Backs Approval For AstraZeneca's Targeted Breast Cancer Therapies

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.